IGJ depletion suppresses proliferation, inflammation, and motility of rheumatoid arthritis fibroblast-like synoviocytes via targeting NF-κB pathway

Int J Rheum Dis. 2024 Aug;27(8):e15282. doi: 10.1111/1756-185X.15282.

Abstract

Objective: To investigate the impact of IGJ on the proliferation, inflammation, and motility of rheumatoid arthritis (RA) fibroblast-like synoviocytes and elucidate the underlying mechanism.

Methods: The expression of IGJ RA fibroblast-like synoviocytes was assessed using immunoblot and qPCR. Cell growth was evaluated using CCK-8 and FCM assays. The effects on inflammatory response were determined by ELISA and immunoblot assays. Cell motility was assessed using transwell and immunoblot assays. The mechanism was further confirmed using immunoblot assays.

Results: IGJ expression was found to be elevated in fibroid synovial cells of RA. IGJ ablation inhibited the growth of MH7A cells and suppressed the inflammatory response. Knockdown of IGJ also blocked cell motility. Mechanically, the knockdown of IGJ suppressed the NF-κB axis in MH7A cells.

Conclusion: IGJ suppresses RA in fibroblast-like synoviocytes via NF-κB pathway.

Keywords: MH7A; NF‐κB pathway; inflammatory response; rheumatoid arthritis (RA) IGJ.

MeSH terms

  • Arthritis, Rheumatoid* / genetics
  • Arthritis, Rheumatoid* / immunology
  • Arthritis, Rheumatoid* / metabolism
  • Arthritis, Rheumatoid* / pathology
  • Cell Line
  • Cell Movement*
  • Cell Proliferation*
  • Cells, Cultured
  • Fibroblasts* / metabolism
  • Fibroblasts* / pathology
  • Humans
  • Hyaluronoglucosaminidase
  • NF-kappa B* / metabolism
  • Signal Transduction*
  • Synoviocytes* / drug effects
  • Synoviocytes* / metabolism
  • Synoviocytes* / pathology

Substances

  • NF-kappa B
  • CEMIP protein, human
  • Hyaluronoglucosaminidase